Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Genomic-Guided Adjuvant Chemotherapy in Early Stage NSCLC
NCT00545948Phase 2Terminated
- Sponsor
- Duke University
- Start
- Dec 2007
- Primary completion
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vinorelbine, pemetrexed in non-small cell lung cancer (NSCLC), sponsored by Duke University. Started Dec 2007; status: terminated.
02
Drugs
vinorelbinepemetrexed
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00545948.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00545948.